Search Results
Nedaplatin 50 mg | 100.00%
TargetMol
Nedaplatin is a derivative of cisplatin and DNA damage agent for tumor colony forming units (IC50: 94 μM). Containing a novel ring structure in which glycolate is bound to the platinum by a bidentate ligand, nedaplatin forms reactive platinum complexes that bind to nucleophilic groups in DNA, resulting in intrastrand and interstrand DNA cross-links, apoptosis […]
More Information Supplier PageNedaplatin 25 mg | 100.00%
TargetMol
Nedaplatin is a derivative of cisplatin and DNA damage agent for tumor colony forming units (IC50: 94 μM). Containing a novel ring structure in which glycolate is bound to the platinum by a bidentate ligand, nedaplatin forms reactive platinum complexes that bind to nucleophilic groups in DNA, resulting in intrastrand and interstrand DNA cross-links, apoptosis […]
More Information Supplier PageNedaplatin 10 mg | 100.00%
TargetMol
Nedaplatin is a derivative of cisplatin and DNA damage agent for tumor colony forming units (IC50: 94 μM). Containing a novel ring structure in which glycolate is bound to the platinum by a bidentate ligand, nedaplatin forms reactive platinum complexes that bind to nucleophilic groups in DNA, resulting in intrastrand and interstrand DNA cross-links, apoptosis […]
More Information Supplier PageTipiracil hydrochloride 100 mg | 99.45%
TargetMol
Tipiralacil is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials.
More Information Supplier PageTucatinib 5 mg | 99.96%
TargetMol
Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor (IC50: 8 nM).
More Information Supplier PageTucatinib 50 mg | 99.96%
TargetMol
Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor (IC50: 8 nM).
More Information Supplier PageTucatinib 10 mg | 99.96%
TargetMol
Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor (IC50: 8 nM).
More Information Supplier PageSTF-31 2 mg | 99.92%
TargetMol
STF-31 is an inhibitor of glucose transporter 1 (GLUT1) with IC50 of 1 μM.
More Information Supplier PageSTF-31 10 mg | 99.92%
TargetMol
STF-31 is an inhibitor of glucose transporter 1 (GLUT1) with IC50 of 1 μM.
More Information Supplier Page
